- Study at RCSI
- Student Life
- Schools & Faculties
- Faculty of Medicine & Health Sciences
- School of Medicine
- School of Pharmacy
- School of Physiotherapy
- School of Postgraduate Studies
- School of Nursing & Midwifery
- Academic Departments
- Institute of Leadership
- Health Professions Education Centre (HPEC)
- Simulation
- Student, Academic & Regulatory Affairs
- Faculty of Sports and Exercise Medicine
- Faculty of Nursing & Midwifery
- Faculty of Dentistry
- Faculty of Radiologists
- Alumni
- Surgical Affairs
- Research & Innovation
- Innovation
- Strategic Academic Recruitment Programme
- Research News & Events
- Research Areas
- Principal Investigators
- Research Networks & Centres
- Technology Cores & Research Facilities
- Research Office
- Employment Opportunities
- PhD Projects and Postgraduate Training Opportunities
- Research Ethics
- Technology Transfer Office & Management of Intellectual Property
- Research by Faculty
- Research by Academic Department
- Research by School
- Human Resources Strategy for Researchers (HRS4R)
- About RCSI
- Council
- CEO and Senior Management
- History
- Annual Report
- Contact us and location
- Communications
- Publications
- Venue hire
- No. 26 York Street
- Athena SWAN
- RCSI and the wider community
- Quality Enhancement Office
- Academic Health Centre
- Irish Society of Urology
- Freedom of Information (FOI)
- Faculty of Medicine & Health Sciences Strategy 2013 - 2017
- Medical Validation Ireland
- Eduroam
- RCSI International
Innovation Quarterly Workshop - Industry Engagement and Research Commercialisation Opportunities with GSK - June 24th
09 May 2016
Venue: VC Room, RCSI, 123 St Stephens Green, Dublin 2
Date & Time: Friday 24 June, 12:30 – 1:30pm
Light refreshments will be served from 12.20 - Speakers will begin at 12:30 pm sharp.
Please RSVP to innovation@rcsi.ie for catering purposes.
Speaker: Dr. Malcolm Skingle - Director of Academic Liaison Worldwide Business Development GSK.
In this workshop, Malcolm will:
• Provide an overview of GSK work with universities around the world and how RCSI researchers can get engage with GSK.
• Outline what GSK looks for in their academic partners.
• Describe how RCSI researchers can develop more strategic research relationship with GSK.
About the Speaker:
Malcolm has BSc in Pharmacology/Biochemistry and a PhD in Neuropharmacology. He has gained a wide breadth of experience in the management of research activities and has more than 60 publications including articles on the interface between industry and academia. For more than a decade he has managed Academic Liaison at GSK managing staff in the UK and US. His role involves close liaison with several groups outside the Company e.g. Government Departments, Research and Funding Councils, Small Biotechnology Companies and other science-driven organisations. He sits on many external bodies including the NC3R’s Board and several UK University Department advisory groups. He also chairs several groups including the Diamond (Synchotron) Industrial Advisory Board and the ABPI group working on academic liaison. Malcolm was awarded a CBE in the 2009 Queen’s Birthday Honours List in recognition of his contribution to the pharmaceutical industry as well as an Honorary Professorship from the College of Medical and Dental Sciences at the University of Birmingham and an honorary DSc from the University of Hertfordshire.